Paracrine sonic hedgehog signaling contributes significantly to acquired steroidogenesis in the prostate tumor microenvironment

Amy A. Lubik,Mannan Nouri,Sarah Truong,Mazyar Ghaffari,Hans H. Adomat,Eva Corey,Michael E. Cox,Na Li,Emma S. Guns,Parvin Yenki,Steven Pham,Ralph Buttyan

DOI: https://doi.org/10.1002/ijc.30450

2016-10-20

International Journal of Cancer

Abstract:Despite the substantial benefit of androgen deprivation therapy (ADT) for metastatic prostate cancer, patients often progress to castration-resistant disease (CRPC) that is more difficult to treat. CRPC is associated with renewed androgen receptor activity in tumor cells and restoration of tumor androgen levels through acquired intratumoral steroidogenesis (AIS). Although prostate cancer (PCa) cells have been shown to have steroidogenic capability in vitro, we previously found that benign prostate stromal cells (PrSCs) can also synthesize testosterone (T) from an adrenal precursor, DHEA, when stimulated with a hedgehog (Hh) pathway agonist, SAG. Here, we show exposure of PrSCs to a different Smoothened (Smo) agonist, Ag1.5, or to conditioned medium from sonic hedgehog overexpressing LNCaP cells induces steroidogenic enzyme expression in PrSCs and significantly increases production of T and its precursor steroids in a Smo-dependent manner from 22-OH-cholesterol substrate. Hh agonist-/ligand-treated PrSCs produced androgens at a rate similar to or greater than that of PCa cell lines. Likewise, primary bone marrow stromal cells became more steroidogenic and produced T under the influence of Smo agonist. Treatment of mice bearing LNCaP xenografts with a Smo antagonist, TAK-441, delayed the onset of CRPC after castration and substantially reduced androgen levels in residual tumors. These outcomes support the idea that stromal cells in ADT-treated primary or metastatic prostate tumors can contribute to AIS as a consequence of a paracrine Hh signaling microenvironment. As such, Smo antagonists may be useful for targeting prostate tumor stromal cell-derived AIS and delaying the onset of CRPC after ADT.

oncology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is how paracrine Sonic Hedgehog (Shh) signaling promotes acquired steroidogenesis (AIS) in the tumor microenvironment of prostate cancer, and further affects the development of castration - resistant prostate cancer (CRPC). Specifically, the research focuses on:

1. **The influence of Shh signaling on prostate stromal cells (PrSCs)**: The research explored how Shh signaling activates the Smoothened (Smo) receptor in stromal cells to induce these cells to express steroid - generating enzymes, thereby increasing the production of testosterone and its precursor steroids.

2. **The steroid - generating ability of bone marrow stromal cells (BMSCs)**: Since bone is the most common metastatic site of prostate cancer, the research also evaluated whether Shh signaling can also activate bone marrow stromal cells for steroidogenesis.

3. **The role of Smo antagonists in inhibiting intratumoral steroidogenesis**: The research tested the effect of a Smo antagonist (TAK - 441) in inhibiting intratumoral steroidogenesis and delaying the development of CRPC in a mouse model.

Through these studies, the paper aims to reveal the mechanism of Hh signaling in the progression of prostate cancer and explore treatment strategies targeting this signaling pathway, with the hope of providing new treatment methods for CRPC patients.